Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2020-08-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
109年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the second quarter and half-year periods of the fiscal year 109 (Taiwan calendar year, corresponding to 2020). It includes actual financial figures such as revenue, costs, expenses, net income, and earnings per share. The presence of substantive financial data for a period shorter than a full fiscal year (quarter and half-year) indicates this is a periodic financial report. The document length is 3732 characters, which is relatively short but contains detailed financial tables, not just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2020-08-13 Chinese
109年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as June 30, 2020 (109年第2季) and December 31, 2019 (108年12月31日). The presence of detailed financial statement line items (assets, liabilities, equity) and amounts indicates this is a financial report rather than an announcement or certification. The document length is 4379 characters, which is relatively short but contains substantive financial data. The document is a quarterly financial report (interim report) as it covers a period shorter than a full fiscal year (second quarter). Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2020-08-13 Chinese
109年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first half of the year 2020 (民國109年上半年度) and the same period in the previous year. It includes line items such as common stock, capital surplus, legal reserve, retained earnings, and other equity components. The presence of actual financial figures and the half-year period indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is 3640 characters, which is relatively short but contains detailed financial tables, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2020-08-13 Chinese
109年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits, referencing the Economic Ministry's investment approval and limits. The content is structured as a regulatory disclosure of investment information rather than a full financial report or announcement. The document length is short (1308 characters), and it does not indicate it is an announcement of a report publication. It is not a management report, earnings release, or audit report. The nature of the data and the regulatory references suggest it is a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-08-13 Chinese
新北市政府勞動檢查處來函說明。
Regulatory Filings Classification · 95% confidence The document is a short announcement (658 characters) from a company (1762 中化生) reporting a regulatory communication from the New Taipei City Government Labor Inspection Office regarding a production halt and subsequent improvement measures. It does not contain financial statements, audit information, or detailed management discussion. It is a regulatory announcement about a labor inspection and operational impact, fitting best under general regulatory filings. The document is not a report, presentation, or financial disclosure but a compliance-related announcement.
2020-08-11 Chinese
109年07月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, chairman, general manager, and other executives, with specific numbers of shares held, increases, decreases, and trust shares. The content focuses on personal share transactions and holdings by company insiders. There is no indication of financial results, earnings, management discussion, or other report types. The document is not a report publication announcement or a certification. The detailed insider shareholding data aligns with the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2020-08-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.